Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment (Gift Article)
New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
We report on the relationship between leukocyte telomere length (LTL), genetics, and environmental factors in ethnically diverse Africans. LTL is longer in African ancestry individuals…
The American Academy of Otolaryngology-Head and Neck Surgery Foundation has released new clinical practice guidelines on identifying and treating patients with age-related hearing loss, or…
Retailers are facing steep challenges as they try to profitably deliver healthcare services.
Several lawmakers questioned whether the company had become so large — with tentacles in every aspect of the nation’s medical care — that the effects…
The legislation, which is expected to be soon signed into law by Democratic Gov. Katie Hobbs, will preserve access to the procedure for millions of…
The scene ends badly, as you might imagine.
In the final results of a randomized trial involving patients with HIV infection, pitavastatin reduced the incidence of adverse cardiovascular events at 5.6 years of…
Nature Communications – Two new gridded, model-ready historical biomass burning emission datasets (BB4CMIPpost and LPJ-LMfirepost) are developed by inverse modeling that leveraged 31 ice core…
A study in a primarily Hispanic population points to the need for improved communication between patients and providers.
Want to hear about JALM’s latest Special Issues, as soon as they publish online? Join our mailing list! Diagnostic Stewardship in Action: Advancing